Insiders · Profile

Egros Fabrice

Director at Syndax Pharmaceuticals. Filing since 1 Mar 2021. CIK 0001597085

Company
Date
Role
Action
Shares
Amount
Of holding
18 Nov 2021
Director
Sold, plan not stated
14,030
$252.99K
46.7%
18 Aug 2021
Director
Sold, plan not stated
15,635
$246.33K
49.4%
18 May 2021
Director
Sold, plan not stated
13,609
$253.78K
46.0%
1 Mar 2021
Director
Sold, plan not stated
10,241
$248.98K
39.0%
4 decisions on file.